Take Solutions Ltd — Investor Relations & Filings
Take Solutions Ltd provides specialized domain-led technology and services, primarily focusing on the Life Sciences sector. Through its key brand, Navitas Life Sciences, the company delivers end-to-end solutions across clinical research, regulatory affairs, and pharmacovigilance. Its service offerings include clinical data management, medical writing, and trial monitoring, leveraging proprietary platforms to enhance operational efficiency. The organization supports pharmaceutical, biotechnology, and medical device companies in managing complex regulatory requirements and streamlining the drug development process. By combining deep functional expertise with digital transformation capabilities, Take Solutions facilitates data-driven decision-making and ensures compliance with global safety standards. Its portfolio encompasses strategic consulting and technology-enabled services designed to optimize clinical trial outcomes and accelerate time-to-market for new therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Press Release | 2026-04-17 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-13 | English | |
| Press Release | 2026-04-06 | English | |
| Change in Auditors | 2026-03-26 | English | |
| Outcome of Board Meeting | 2026-03-26 | English | |
| Resignation | 2026-03-25 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42209881 | Press Release | 2026-04-17 | English | ||
| 42189767 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-13 | English | ||
| 42213664 | Press Release | 2026-04-06 | English | ||
| 42163155 | Change in Auditors | 2026-03-26 | English | ||
| 42163370 | Outcome of Board Meeting | 2026-03-26 | English | ||
| 42178686 | Resignation | 2026-03-25 | English | ||
| 42179973 | Trading Window | 2026-03-25 | English | ||
| 42190231 | Press Release | 2026-03-25 | English | ||
| 42170276 | General Updates | 2026-03-11 | English | ||
| 42187987 | Shareholders meeting | 2026-03-07 | English | ||
| 42188107 | Shareholders meeting | 2026-03-07 | English | ||
| 42193993 | Press Release | 2026-02-21 | English | ||
| 42175686 | Record Date | 2026-02-18 | English | ||
| 42183715 | Copy of Newspaper Publication | 2026-02-17 | English | ||
| 42189888 | Press Release | 2026-02-17 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
NanoSphere Health Sciences Inc.
Nano-biotechnology firm creating advanced drug delivery sys…
|
NSHS | CA | Professional, scientific and te… |
|
NANOVIRICIDES, INC.
Clinical-stage biopharma developing broad-spectrum, nanomed…
|
NNVC | US | Professional, scientific and te… |
|
Natcore Technology Inc.
R&D entity using nanotechnology to improve solar cell effic…
|
NTCXF | CA | Professional, scientific and te… |
|
Nautilus Biotechnology, Inc.
Develops a proteome analysis platform to quantify proteins …
|
NAUT | US | Professional, scientific and te… |
|
NeoImmuneTech, Inc.
A clinical-stage biopharma developing T cell-focused immuno…
|
950220 | US | Professional, scientific and te… |
|
Neovacs
Biotech firm developing immunotherapies and investing in Bi…
|
ALNEV | FR | Professional, scientific and te… |
|
NervGen Pharma Corp.
Clinical-stage biotech developing treatments to promote ner…
|
NGEN | CA | Professional, scientific and te… |
|
NEUREN PHARMACEUTICALS LIMITED
Develops innovative therapies for rare neurodevelopmental d…
|
NEU | NZ | Professional, scientific and te… |
|
NEURIZON THERAPEUTICS LIMITED
Clinical-stage developer of mTOR modulators for ALS and neu…
|
NUZ | AU | Professional, scientific and te… |
|
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
Develops peptide-based therapeutics for neurodegenerative a…
|
NSB | AU | Professional, scientific and te… |
Take Solutions Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60381/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60381 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60381 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60381 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60381}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Take Solutions Ltd (id: 60381)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.